Journal profile · Ophthalmology
Ophthalmic Genetics
ISSN 1381-6810 · eISSN 1744-5094 · Taylor and Francis Ltd. · UNITED STATES · Quarterly · Founded 1994
Ophthalmic Genetics: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 0.94; hybrid open access; APC charged, amount not published; median 158 days to acceptance (106 articles, last 24 months); community-reported acceptance: easy; 125 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Ophthalmic Genetics is published by Taylor and Francis Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Retinal Development and Disorders, Retinal Diseases and Treatments and Ocular Disorders and Treatments, together about 40.3% of its articles. Its main subfields are Ophthalmology. (generated from OpenAlex topic counts and CAS ranking data)
Ophthalmic Genetics is a subscription-based, peer-reviewed journal that focuses on publishing high-quality research and clinical studies related to the clinical and molecular genetic aspects of ocular diseases. The journal’s audience includes geneticists, ophthalmologists, researchers, and clinicians interested in the genetic basis, mechanisms, diagnosis, and treatment of ocular diseases. The journal has a special interest in advancing knowledge on the genetic mechanisms underlying eye disorders and their clinical applications, providing new insights into the diagnosis and management of inherited ocular conditions. The journal welcomes for consideration Research Articles, Methods, Case Reports, Letters to the Editor, Review Articles, Data Notes, Editorials, and Pictorial Works. All articles received by the journal will be subject to single anonymous peer review. Authors can choose to publish gold open access in this journal. Read the Instructions for Authors for detailed submission requirements and information on how to submit your article.
From the journal's Aims & Scope
Research area (LetPub): Ophthalmology
Editor-in-chief Brian P. BrooksPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Retinal Development and DisordersBiochemistry, Genetics and Molecular Biology20.3%
- Retinal Diseases and TreatmentsMedicine11%
- Ocular Disorders and TreatmentsBiochemistry, Genetics and Molecular Biology8.9%
- Glaucoma and retinal disordersMedicine6.9%
- Ocular Oncology and TreatmentsMedicine5%
- Retinal and Macular SurgeryMedicine4.1%
- Connexins and lens biologyBiochemistry, Genetics and Molecular Biology4%
- Corneal surgery and disordersMedicine3.7%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Genetics & Heredity | Zone 4 |
| Minor | Ophthalmology | Zone 4 |
Top journal: noReview journal: no
JCR / CiteScore quartiles on the journal's website
- CiteScore Q2 · 2025
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceMEDLINEPubMedEmbaseCurrent ContentsPublisher website
Other: ProQuest, OCLC, Adis International Ltd., EBSCOhost, MetaPress, Personal Alert (E-mail)
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 0.94LetPub ·
- Impact factor (publisher) 2025
- 1Publisher website ·
- 5-year impact factor (publisher) 2025
- 1.3Publisher website ·
- CiteScore 2026-06
- 2.1LetPub ·
- CiteScore (publisher) 2025
- 2.1Publisher website ·
- SJR 2026-06
- 0.45LetPub ·
- SJR (publisher) 2025
- 0.45Publisher website ·
- SNIP 2026-06
- 0.72LetPub ·
- SNIP (publisher) 2025
- 0.72Publisher website ·
- h-index
- 36LetPub ·
- h-index
- 56OpenAlex ·
- i10-index
- 848OpenAlex ·
- 2-year mean citedness
- 0.87OpenAlex ·
- Self-citation rate
- 10%LetPub ·
- Share of gold OA articles
- 12.72%LetPub ·
Volume
- Articles per year
- 119LetPub ·
- Articles per year (publisher)
- 322Publisher website ·
- Downloads per year (publisher)
- 127,000Publisher website ·
Articles by year OpenAlex count · 2,152 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 101 | 28 | 5 |
| 2025 | 125 | 41 | 109 |
| 2024 | 91 | 28 | 161 |
| 2023 | 75 | 27 | 235 |
| 2022 | 148 | 44 | 671 |
| 2021 | 135 | 39 | 1,149 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
158 daysMedian, submission to acceptance · P25–P75 119 days – 217 days
- Acceptance to online
- median 14 days (106 articles)
- Submission to online
- median 184 days
- Sample
- 106 articles with submission and acceptance dates (245 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
- Acceptance rate (publisher)
- 47%Publisher website ·
- Submission to first decision
- 45 daysPublisher website ·
- First decision after review
- 81 daysPublisher website ·
- Acceptance to publication
- 23 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | Yes, amount not published | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted8
- case reportsThe journal welcomes for consideration Research Articles, Methods, Case Reports, Letters to the Editor, Review Articles, Data Notes, Editorials, and Pictorial W…Length not stated
- data notesThe journal welcomes for consideration Research Articles, Methods, Case Reports, Letters to the Editor, Review Articles, Data Notes, Editorials, and Pictorial W…Length not stated
- editorialsThe journal welcomes for consideration Research Articles, Methods, Case Reports, Letters to the Editor, Review Articles, Data Notes, Editorials, and Pictorial W…Length not stated
- letters to the editorThe journal welcomes for consideration Research Articles, Methods, Case Reports, Letters to the Editor, Review Articles, Data Notes, Editorials, and Pictorial W…Length not stated
- methodsThe journal welcomes for consideration Research Articles, Methods, Case Reports, Letters to the Editor, Review Articles, Data Notes, Editorials, and Pictorial W…Length not stated
- pictorial worksThe journal welcomes for consideration Research Articles, Methods, Case Reports, Letters to the Editor, Review Articles, Data Notes, Editorials, and Pictorial W…Length not stated
- research articlesThe journal welcomes for consideration Research Articles, Methods, Case Reports, Letters to the Editor, Review Articles, Data Notes, Editorials, and Pictorial W…Length not stated
- review articlesThe journal welcomes for consideration Research Articles, Methods, Case Reports, Letters to the Editor, Review Articles, Data Notes, Editorials, and Pictorial W…Length not stated
Policy excerpts from the journal's websiteOpen access, Peer review
- Open access Open access
Ophthalmic Genetics is a hybrid open access journal that is part of the Taylor & Francis Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research. Why choose open access? Increase the discoverability and rea…
Source ↗Publisher website ·- Peer review
All articles received by the journal will be subject to single anonymous peer review. Model summary
All articles received by the journal will be subject to single anonymous peer review.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Taylor and Francis Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1994
- ISSN
- 1381-6810
- Electronic ISSN
- 1744-5094
- Society / sponsor
- International Society for Genetic Eye Diseases and Retinoblastoma
- Latest issue on the website
- Volume 47, Issue 4 (2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Ophthalmic Genetics
What CAS zone is Ophthalmic Genetics in?
In the 2025 upgraded edition of the CAS Journal Ranking, Ophthalmic Genetics is in Zone 4 of Medicine, and in Zone 4 of the minor category Genetics & Heredity / Ophthalmology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Ophthalmic Genetics?
The latest impact factor listed by LetPub is 0.94; CiteScore 2.1, h-index 56.
How long does peer review take at Ophthalmic Genetics?
Based on the dates recorded on 106 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 158 days (interquartile range 119–217 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”; the journal's website gives an acceptance rate of 47%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Ophthalmic Genetics?
According to LetPub and DOAJ records, Ophthalmic Genetics is indexed in SCIE and Scopus. The journal's website also lists Web of Science, MEDLINE, PubMed, Embase and Current Contents; that list has not been checked against each database.
Is Ophthalmic Genetics open access, and what is the APC?
Ophthalmic Genetics is a hybrid journal. For open-access publication: APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .